Venclose Maven Catheter
Payments companies reported to CMS as associated with Venclose Maven Catheter. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Venclose Maven Catheter, per program year, as reported to CMS.
Who makes it
- Bard Peripheral Vascular, INC. $355K associated with Venclose Maven Catheter (2023-2025)
- Becton, Dickinson and Company $20K associated with Venclose Maven Catheter (2023-2025)
- Davol INC. $525 associated with Venclose Maven Catheter (2023-2025)
- C. R. Bard, INC. & Subsidiaries $392 associated with Venclose Maven Catheter (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Venclose Maven Catheter
These are the largest totals companies reported as associated with Venclose Maven Catheter. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christopher Ninh | Fountain Valley, CA | Orthopaedic Surgery | $33,552.61 |
| Tammy Ramos | Omaha, NE | Vascular Surgery | $10,125.00 |
| Ian Katz | Decatur, GA | $10,125.00 | |
| Joseph Vardayo | Long Beach, CA | Vascular Surgery | $9,956.25 |
| John Chang | Coral Gables, FL | Surgery | $9,916.97 |
| Anoop Thakur | Battle Creek, MI | Psychiatry | $9,731.25 |
| Stephen Chastain | Stuart, FL | Cardiovascular Disease | $9,686.25 |
| Michael Aziz | New York, NY | Internal Medicine | $8,124.26 |
| Joseph Ghazal | Los Angeles, CA | Cardiovascular Disease | $5,043.06 |
| Lowell Kabnick | Morristown, NJ | $5,036.36 |
Prescribed Venclose Maven Catheter?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.